ATLANTA, May 17, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of inoffice, accessible, and innovative therapeutic and diagnostic products, announces CEO and Founder Kathy LeeSepsick has met with staff from the White House Office of Science and Technology Policy (OSTP) to discuss the President and First Lady's Cancer Moonshot and the Company's FemCerv® product. According to The White ...